Screening adults for pre-diabetes and diabetes may be cost-saving

Diabetes Care

Volumn 33, Issue 7, 2010, Pages 1484-1490

  Chatterjee, Ranee ^a,b   Narayan, K M Venkat ^a,c   Lipscomb, Joseph ^a,d   Phillips, Lawrence S ^c,d  

^a EMORY UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; METFORMIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; COST CONTROL; DIABETES MELLITUS; DRUG COST; FALSE NEGATIVE RESULT; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE; HEALTH CARE COST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; ORAL GLUCOSE TOLERANCE TEST; SCREENING; BLOODBORNE BACTERIUM; COST BENEFIT ANALYSIS; DISEASE COURSE; ECONOMICS; GLUCOSE TOLERANCE TEST; GOVERNMENT; HYPERGLYCEMIA; LABORATORY DIAGNOSIS; MASS SCREENING; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED STATES;

BLOOD-BORNE PATHOGENS; COST SAVINGS; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; MALE; MASS SCREENING; MEDICARE; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 77958166549     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0054     Document Type: Article

References (25)

1. American Diabetes Association. Executive summary: Standards of medical care in diabetes-2008. Diabetes Care 2008;31(Suppl. 1):S5-S11
2. Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 2004;27:9-12
3. Leiter LA, Barr A, Bélanger A, Lubin S, Ross SA, Tildesley HD, Fontaine N, Diabetes Screening in Canada (DIASCAN) Study. Diabetes Screening in Canada (DIASCAN) study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. Diabetes Care 2001;24:1038-1043
4. Kenealy T, Elley CR, Arroll B. Screening for diabetes and prediabetes. Lancet 2007;370:1888-1889
5. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000;23:1563-1580
6. Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM. Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diabetes Care 2003;26:2536-42
7. Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med 2004;140:689-99
8. Zhang P, Engelgau MM, Valdez R, Cadwell B, Benjamin SM, Narayan KM. Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis. Diabetes Care 2005;28:1321-5
9. Johnson SL, Tabaei BP, Herman WH. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. Diabetes Care 2005;28:307-11
10. Kim C, Herman WH, Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 2007;30:1102-6
11. Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care 2007;30:2874-9
12. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008;336:1180-5
13. Phillips LS, Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Chatterjee R, Narayan KM, Koch DD. Glucose challenge test screening for prediabetes and undiagnosed diabetes. Diabetologia 2009;52:1798-807
14. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 2004;53:2095-100
15. Blackmore CC, Terasawa T. Optimizing the interpretation of CT for appendicitis: modeling health utilities for clinical practice. J Am Coll Radiol 2006;3:115-121
16. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
17. Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003;26:2518-2523
18. Trogdon JG, Hylands T. Nationally representative medical costs of diabetes by time since diagnosis. Diabetes Care 2008;31:2307-2311
19. Nichols GA, Brown JB. Higher medical care costs accompany impaired fasting glucose. Diabetes Care 2005;28:2223-2229
20. Nichols GA, Arondekar B, Herman WH. Medical care costs one year after identification of hyperglycemia below the threshold for diabetes. Medical Care 2008;46:287-292
21. American Diabetes Association. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615
22. Brown JB, Nichols GA, Glauber HS, Bakst AW. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 1999;22: 1116-24
23. Johnson JA, Pohar SL, Majumdar SR. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study. Diabetes Care 2006;29:2403-8
24. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-94
25. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334